Observational studyPloS one2025

A real-world pharmacovigilance analysis of acute renal failure associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS).

Shiyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.